China Regenerative Medicine International Limited (HKG:8158)
0.3600
-0.0150 (-4.00%)
Feb 13, 2026, 4:08 PM HKT
HKG:8158 Balance Sheet
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 7.28 | 22.7 | 3.33 | 1.85 | 9.93 | 4.77 |
Cash & Short-Term Investments | 7.28 | 22.7 | 3.33 | 1.85 | 9.93 | 4.77 |
Cash Growth | 294.26% | 580.92% | 80.31% | -81.38% | 108.29% | -98.48% |
Accounts Receivable | 0.94 | 0.62 | 1.2 | 0.07 | 0.21 | 0.08 |
Other Receivables | 38.51 | 28.02 | 156.43 | 237.71 | 196.91 | 116.89 |
Receivables | 39.45 | 28.64 | 157.63 | 237.78 | 197.12 | 116.97 |
Inventory | 0.3 | 0.24 | 0.45 | 0.29 | 0.38 | 1.38 |
Prepaid Expenses | 0.13 | 0.16 | 0.19 | 2.56 | 41.36 | 8.6 |
Other Current Assets | 5.95 | 6.58 | 6.99 | 6.62 | 9.59 | 11.9 |
Total Current Assets | 53.1 | 58.31 | 168.58 | 249.09 | 258.39 | 143.62 |
Property, Plant & Equipment | 27.67 | 6.99 | 17.32 | 26.82 | 0.75 | 1.3 |
Other Long-Term Assets | 77.13 | 70.41 | - | - | - | 7.57 |
Total Assets | 157.9 | 135.71 | 185.9 | 275.91 | 259.14 | 152.49 |
Accounts Payable | 1.66 | 3.84 | 2.47 | 0.05 | 0.09 | 8 |
Accrued Expenses | 11.99 | 8.67 | 13.11 | 7.65 | 3.71 | 13.74 |
Current Portion of Long-Term Debt | 3.63 | 3.63 | 13.63 | 48.41 | 29.95 | 20.3 |
Current Portion of Leases | 7.99 | 4.59 | 10.4 | 9.92 | 5.87 | 17.03 |
Current Income Taxes Payable | 24.87 | 24.87 | 25.29 | 25.57 | 24.26 | 12.56 |
Current Unearned Revenue | 9.63 | 11.29 | 81.09 | 60.74 | 76.6 | 9.16 |
Other Current Liabilities | - | 1.98 | 1.81 | 5.82 | 6.83 | 120.31 |
Total Current Liabilities | 59.76 | 58.87 | 147.79 | 158.17 | 147.31 | 201.1 |
Long-Term Debt | 47.43 | 45.47 | 21.58 | - | - | - |
Long-Term Leases | 17 | - | 4.59 | 13.68 | - | 5.87 |
Long-Term Deferred Tax Liabilities | 0.15 | 0.15 | 0.15 | 0.15 | 0.1 | 0.67 |
Other Long-Term Liabilities | 4.5 | 6.02 | - | - | - | - |
Total Liabilities | 128.84 | 110.51 | 174.1 | 172 | 147.41 | 207.64 |
Common Stock | 60.85 | 60.85 | 60.85 | 570.86 | 570.86 | 570.86 |
Additional Paid-In Capital | 3,216 | 3,216 | 3,216 | 3,204 | 3,204 | 3,204 |
Retained Earnings | -2,859 | -2,863 | -2,881 | -3,287 | -3,292 | -3,305 |
Comprehensive Income & Other | -388.97 | -388.23 | -383.88 | -383.46 | -371.09 | -411.34 |
Total Common Equity | 29.06 | 25.2 | 11.79 | 103.92 | 111.73 | 58.13 |
Minority Interest | - | - | - | - | - | -113.28 |
Shareholders' Equity | 29.06 | 25.2 | 11.79 | 103.92 | 111.73 | -55.15 |
Total Liabilities & Equity | 157.9 | 135.71 | 185.9 | 275.91 | 259.14 | 152.49 |
Total Debt | 76.05 | 53.69 | 50.19 | 72.01 | 35.82 | 43.19 |
Net Cash (Debt) | -68.77 | -30.99 | -46.86 | -70.16 | -25.9 | -38.43 |
Net Cash Per Share | -0.23 | -0.10 | -0.16 | -0.25 | -0.09 | -0.24 |
Filing Date Shares Outstanding | 304.25 | 304.25 | 304.25 | 285.43 | 285.43 | 285.43 |
Total Common Shares Outstanding | 304.25 | 304.25 | 304.25 | 285.43 | 285.43 | 285.43 |
Working Capital | -6.66 | -0.56 | 20.79 | 90.93 | 111.08 | -57.48 |
Book Value Per Share | 0.10 | 0.08 | 0.04 | 0.36 | 0.39 | 0.20 |
Tangible Book Value | 29.06 | 25.2 | 11.79 | 103.92 | 111.73 | 58.13 |
Tangible Book Value Per Share | 0.10 | 0.08 | 0.04 | 0.36 | 0.39 | 0.20 |
Machinery | - | 6.44 | 6.47 | 53.66 | 53.4 | 53.89 |
Leasehold Improvements | - | 22.19 | 21.74 | 104.15 | 101.82 | 101.82 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.